Top Left Logo
COVID-19 Vaccines Healthy People, Healthy Communities
Skip Navigation Links
For Health Professionals
Contact Us

Spacer Spacer Spacer Spacer
Index      Small Text Medium Text Large Text  

AstraZeneca Information

About AstraZeneca
Newfoundland and Labrador public health officials paused the administration of the AstraZeneca/COVISHIELD vaccine for adults under age 55 on March 29, 2021. This decision was based on new guidelines from the National Advisory Committee on Immunization, which cites European reports of rare instances of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) in people four to 20 days after receiving the AstraZeneca vaccine.
Health Canada has approved the use of the AstraZeneca COVID-19 vaccine. For additional information on this vaccine and others, please visit Health Canada’s website at 


Updated May 17, 2021